Akanda Corp. (NASDAQ:AKAN) Sees Large Decrease in Short Interest

Akanda Corp. (NASDAQ:AKANGet Free Report) was the target of a significant decrease in short interest in the month of June. As of June 30th, there was short interest totaling 18,178 shares, a decrease of 87.0% from the June 15th total of 139,841 shares. Currently, 4.2% of the company’s stock are sold short. Based on an average daily volume of 44,335 shares, the days-to-cover ratio is presently 0.4 days.

Analysts Set New Price Targets

A number of research firms have recently weighed in on AKAN. Weiss Ratings downgraded shares of Akanda from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Monday, May 18th. Wall Street Zen raised shares of Akanda to a “sell” rating in a report on Saturday, May 30th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has an average rating of “Sell”.

Read Our Latest Stock Report on Akanda

Akanda Stock Down 1.1%

AKAN stock traded down $0.11 during trading on Friday, hitting $9.94. 16,114 shares of the company’s stock traded hands, compared to its average volume of 309,926. Akanda has a 52 week low of $2.30 and a 52 week high of $209.02. The stock has a fifty day moving average price of $19.04 and a two-hundred day moving average price of $10.71.

Akanda (NASDAQ:AKANGet Free Report) last issued its earnings results on Tuesday, June 9th. The company reported ($317.90) EPS for the quarter.

Akanda Company Profile

(Get Free Report)

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.

See Also

Receive News & Ratings for Akanda Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akanda and related companies with MarketBeat.com's FREE daily email newsletter.